A research team at the Institute of Neurosciences of the University of Barcelona (UBneuro) has led a study describing a new molecular mechanism that affects RNA processing and alters the process of protein synthesis in the brains of Alzheimer’s patients.
AbbVie’s Pharmacyclics files patent suit against BeiGene over BTK rival Brukinsa
Pharmacyclics is bringing its BTK battle to court. The AbbVie unit filed suit against BeiGene on Tuesday, alleging the company’s competing blood cancer drug Brukinsa